Remimazolam

Generic Name
Remimazolam
Brand Names
Byfavo
Drug Type
Small Molecule
Chemical Formula
C21H19BrN4O2
CAS Number
308242-62-8
Unique Ingredient Identifier
7V4A8U16MB
Background

Remimazolam is an ultra short-acting benzodiazepine used in the induction and maintenance of sedation during short (<30 minute) procedures. Recent trends in anesthesia-related drug development have touted the benefits of so-called "soft drugs" - these agents, such as remifentanil, are designed to be metabolically fragile and thus susceptible to rapid biotran...

Indication

Remimazolam is indicated for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less.

Associated Conditions
Procedural Sedation
Associated Therapies
-

REmimazolam vs Propofol Total Intravenous Anesthesia on Outcomes After Major Noncardiac SurgEry

First Posted Date
2023-02-15
Last Posted Date
2023-04-07
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
7188
Registration Number
NCT05728775
Locations
🇨🇳

Beijing Chaoyang Hospital, Capital Medical University, Beijing, Beijing, China

🇨🇳

Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China

🇨🇳

The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China

and more 14 locations

Comparison of Recovery Profiles Among Propofol, Remimazolam, and Dexmedetomidine After Intraoperative Sedation

First Posted Date
2023-01-18
Last Posted Date
2024-01-31
Lead Sponsor
Asan Medical Center
Target Recruit Count
120
Registration Number
NCT05688345
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

Remiazolam Combined With Esketamine in Painless Bidirectional Endoscopy in Children

First Posted Date
2023-01-17
Last Posted Date
2023-08-21
Lead Sponsor
Tongji Hospital
Target Recruit Count
106
Registration Number
NCT05686863
Locations
🇨🇳

Tongji Hospital, Wuhan, Hubei, China

Comparison in Frequency of Hypotension Between Remimazolam and Propofol in Hip Surgery

First Posted Date
2022-12-15
Last Posted Date
2023-02-06
Lead Sponsor
Asan Medical Center
Target Recruit Count
78
Registration Number
NCT05651399
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

Effect of Remimazolam and Propofol on Hemodynamic Stability in Prone Position

Phase 4
Recruiting
Conditions
Interventions
First Posted Date
2022-12-09
Last Posted Date
2022-12-09
Lead Sponsor
Asan Medical Center
Target Recruit Count
94
Registration Number
NCT05644483
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

Remimazolam Versus Propofol for Painless Abortion

First Posted Date
2022-12-02
Last Posted Date
2022-12-02
Lead Sponsor
Maternal and Child Health Hospital of Hubei Province
Target Recruit Count
100
Registration Number
NCT05635955
Locations
🇨🇳

Maternal and Child Health Hospital of Hubei Province, Wuhan, Hubei, China

Comparison of the Effect of Remimazolam and Propofol on Perioperative Hypothermia Under Spinal Anesthesia

First Posted Date
2022-10-10
Last Posted Date
2022-10-10
Lead Sponsor
Wonkwang University Hospital
Target Recruit Count
82
Registration Number
NCT05574257
Locations
🇰🇷

Wonkwag UH, Iksan, Jeollabukdo, Korea, Republic of

Effects of Remimazolam on the Intraoperative Hemodynamics in Bypass Surgery

Not Applicable
Recruiting
Conditions
Interventions
First Posted Date
2022-09-27
Last Posted Date
2022-10-27
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
72
Registration Number
NCT05557253
Locations
🇰🇷

Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of

Differential Effects of Remimazolam and Propofol on Dynamic Cerebral Autoregulation During General Anesthesia

First Posted Date
2022-09-09
Last Posted Date
2022-09-29
Lead Sponsor
Second Affiliated Hospital of Nanchang University
Target Recruit Count
50
Registration Number
NCT05533580
Locations
🇨🇳

the Second Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, Jiangxi, China

Electroencephalographic Profiles During General Anesthesia: a Comparative Study of Remimazolam and Propofol

First Posted Date
2022-09-09
Last Posted Date
2022-09-29
Lead Sponsor
Second Affiliated Hospital of Nanchang University
Target Recruit Count
12
Registration Number
NCT05533567
Locations
🇨🇳

the Second Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, Jiangxi, China

© Copyright 2024. All Rights Reserved by MedPath